142 related articles for article (PubMed ID: 9457254)
1. An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer.
Uzoaru I; Rubenstein M; Mirochnik Y; Slobodskoy L; Shaw M; Guinan P
J Surg Oncol; 1998 Jan; 67(1):33-7. PubMed ID: 9457254
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.
Stapleton AM; Zbell P; Kattan MW; Yang G; Wheeler TM; Scardino PT; Thompson TC
Cancer; 1998 Jan; 82(1):168-75. PubMed ID: 9428494
[TBL] [Abstract][Full Text] [Related]
3. Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy.
Khoo VS; Pollack A; Cowen D; Joon DL; Patel N; Terry NH; Zagars GK; von Eschenbach AC; Meistrich ML; Troncoso P
Prostate; 1999 Nov; 41(3):166-72. PubMed ID: 10517874
[TBL] [Abstract][Full Text] [Related]
4. PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study.
Kim SH; Park WS; Park BR; Joo J; Joung JY; Seo HK; Chung J; Lee KH
Asian J Androl; 2017; 19(4):458-462. PubMed ID: 27232854
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of Ki-67, p53 protein, and DNA content in the diagnosis of gastric carcinoma.
Igarashi N; Takahashi M; Ohkubo H; Omata K; Iida R; Fujimoto S
Cancer; 1999 Oct; 86(8):1449-54. PubMed ID: 10526272
[TBL] [Abstract][Full Text] [Related]
6. Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.
Railo M; Lundin J; Haglund C; von Smitten K; von Boguslawsky K; Nordling S
Acta Oncol; 1997; 36(4):369-74. PubMed ID: 9247096
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
8. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.
Allegra CJ; Parr AL; Wold LE; Mahoney MR; Sargent DJ; Johnston P; Klein P; Behan K; O'Connell MJ; Levitt R; Kugler JW; Tria Tirona M; Goldberg RM
J Clin Oncol; 2002 Apr; 20(7):1735-43. PubMed ID: 11919229
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tumor markers in colorectal cancer patients: DNA index, S-phase fraction, p53 expression, and Ki-67 index.
Chen YT; Henk MJ; Carney KJ; Wong WD; Rothenberger DA; Zheng T; Feygin M; Madoff RD
J Gastrointest Surg; 1997; 1(3):266-72; discussion 273. PubMed ID: 9834357
[TBL] [Abstract][Full Text] [Related]
11. Frequency of Ki-67 (MIB-1) and P53 expressions among patients with prostate cancer.
Madani SH; Ameli S; Khazaei S; Kanani M; Izadi B
Indian J Pathol Microbiol; 2011; 54(4):688-91. PubMed ID: 22234091
[TBL] [Abstract][Full Text] [Related]
12. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.
Cheng L; Sebo TJ; Cheville JC; Pisansky TM; Slezak J; Bergstralh EJ; Pacelli A; Neumann RM; Zincke H; Bostwick DG
Cancer; 1999 Mar; 85(6):1293-9. PubMed ID: 10189134
[TBL] [Abstract][Full Text] [Related]
13. p53 expression, proliferation marker Ki-S5, DNA content and serum PSA: possible biopotential markers in human prostatic cancer.
Papadopoulos I; Rudolph P; Wirth B; Weichert-Jacobsen K
Urology; 1996 Aug; 48(2):261-8. PubMed ID: 8753738
[TBL] [Abstract][Full Text] [Related]
14. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers in clinically localised prostate cancer.
Bai XZ; Masters JR; O'Donoghue N; Kirby R; Pan LX; Young M; Stafford M; Parkinson MC
Int J Oncol; 1999 Apr; 14(4):785-91. PubMed ID: 10087330
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of MiB1 and p53 expression in human bladder tumors and their correlation with cancer progression.
Pfister C; Buzelin F; Casse C; Bochereau G; Buzelin JM; Bouchot O
Eur Urol; 1998; 33(3):278-84. PubMed ID: 9555552
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy.
Moul JW
Eur Urol; 1999; 35(5-6):399-407. PubMed ID: 10325496
[TBL] [Abstract][Full Text] [Related]
18. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
Sasor A; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of p53 and DNA ploidy following radical prostatectomy.
Deliveliotis C; Skolarikos A; Karayannis A; Tzelepis V; Trakas N; Alargof E; Protogerou V
World J Urol; 2003 Aug; 21(3):171-6. PubMed ID: 12844233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
